Following the publication of the results of the ADOPT study, GlaxoKlineSmith, the makers of Avandia have been touting the finding that Avandia delayed the progression from "Monotherapy" i.e. taking one drug to taking additional drugs better than Metformin.In the diabetes oral drug sweepstakes, they'd have you believe that Avandia is the "winner." What was missed in this interpretation was that
